Haris Ashley
Wegovy® (semaglutide) injection 2.4 mg is a prescription medication used to reduce the risk of major cardiovascular events in adults with obesity or overweight. It is also used to help adults and children aged 12 years and older with obesity or overweight-related medical problems to lose weight and maintain weight loss. While Wegovy has been praised as a highly effective medication for obesity, it is not covered by all insurance plans, and patients have reported struggling to get insurance coverage for the drug.
| Characteristics | Values |
|---|---|
| Availability of insurance coverage | Varies by plan |
| Cost | Varies by plan |
| Cost without insurance | $849 per month |
| Cost with NovoCare savings program | $650 per month |
| Cost with insurance | Depends on the plan and eligibility requirements |
| Eligibility requirements | Adults must have an initial body mass index (BMI) of 30 or higher or an initial BMI of 27 or higher (overweight) with at least one weight-related medical condition |
| Prior authorization | Required by some prescription insurance plans |
| Side effects | Pancreatitis, gallbladder problems, thyroid tumors, and thyroid cancer |
Explore related products
What You'll Learn
Cost and coverage
The cost of Wegovy® varies depending on your insurance plan and coverage. Wegovy® is a prescription medication used to treat obesity and reduce the risk of cardiovascular events in adults with heart disease who are either overweight or obese. It is an injectable medicine containing semaglutide and is used alongside a reduced-calorie diet and increased physical activity.
The cost of Wegovy® can be high, and some insurance companies may not cover it. Medicare, for example, does not cover weight-loss medications, and employer-provided insurance plans may also not include it. In such cases, NovoCare, sponsored by the manufacturer of Wegovy®, Novo Nordisk, offers a savings program that can reduce the cost to $650 per month.
To find out if your insurance plan covers Wegovy®, you can use the online resources provided by Wegovy® and NovoCare. These resources allow you to check your estimated cost and whether your insurance plan offers coverage for Wegovy®. It is important to note that each insurance plan is different, and coverage for Wegovy® may depend on various factors, including your state of residence and the reason for using the medication.
If your insurance plan does not cover Wegovy®, you can explore other options. You can ask your healthcare provider to write a letter to your human resources department or your insurance company to request coverage. Additionally, prior authorization may be required by your insurance plan, which means your healthcare provider will need to submit a form for approval. It is recommended to check with your insurance provider directly to confirm the accuracy of the coverage information.
Hearing Aids: Are They Covered by Medical Insurance?
You may want to see also
Explore related products
Insurance coverage options
Insurance coverage for Wegovy® varies depending on the insurance provider and the individual's plan. It is recommended to check with your specific insurance provider to determine if Wegovy® is covered under your plan. Some insurance plans may cover Wegovy® for cardiovascular risk reduction, especially after its approval by the FDA for this use in 2024, but this varies by plan.
Medicare, for example, does not typically cover weight-loss medications and does not allow the use of manufacturer's coupons with their Part D plan. However, some Medicare prescription plans may cover Wegovy® for cardiovascular risk reduction. Additionally, Medicaid coverage for Wegovy® depends on the state and the reason for its use. As of January 2025, 14 states cover GLP-1 receptor agonists, such as Wegovy®.
For individuals without insurance or whose insurance does not cover Wegovy®, NovoCare, sponsored by the manufacturer of Wegovy®, offers a savings program that can reduce the cost to $650 per month. This program can also help those whose out-of-pocket cost exceeds $849 per month.
If your insurance plan does not cover Wegovy®, you can explore the option of requesting a letter from your healthcare provider to your human resources department or insurance company. It is also essential to note that prior authorizations may be required by some prescription insurance plans before covering Wegovy®.
Deducting Medical Insurance: When Employers Don't Contribute
You may want to see also
Explore related products
![[8 Pack 4" x 5 Yards] Beige-Self Adhesive Cohesive Bandage Wrap, Self Adherant Non-Woven Wrap Rolls, Atheletic Tape for Wrist, Ankle, Hand, Leg, Premium-Grade Medical Stretch Wrap](https://m.media-amazon.com/images/I/81wGnSXRl8L._AC_UL320_.jpg)
Prior authorization
It is important to note that prior authorization for Wegovy may also depend on whether you have tried other lower-cost medications for weight loss first. Some insurance plans will only cover Wegovy if you have already tried a cheaper weight loss medication without success. Your healthcare provider can list these medications on the prior authorization form. Additionally, prior authorization approval for Wegovy may only be valid for a certain period. It is advisable to check with your insurance company about the duration of the approval.
The process of obtaining prior authorization typically involves your healthcare provider or their staff completing the form on your behalf. You will need to provide them with information such as your contact details and date of birth. It is likely that your healthcare provider has experience completing these forms, so they can guide you through the process and inform you of any additional requirements. If your prior authorization for Wegovy is denied, you do have the option to appeal the decision.
It is worth noting that insurance coverage for Wegovy can vary depending on your specific plan. It is recommended to check with your insurance company to verify if your plan covers Wegovy and to understand the estimated cost. If your employer-provided insurance plan does not cover Wegovy, you can request that your healthcare provider writes a letter to your human resources department. This can be a way to seek coverage for the medication.
University Insurance and Medicaid: Can You Have Both?
You may want to see also
Explore related products
Insurance plan requirements
Firstly, Wegovy is a prescription medication used to treat obesity and reduce the risk of cardiovascular events in adults with heart disease who are either overweight or obese. Therefore, insurance plans may require that patients meet specific body mass index (BMI) criteria, typically an initial BMI of 30 or higher, or an initial BMI of 27 or higher with at least one weight-related medical condition.
Secondly, prior authorization (PA) may be necessary for some prescription insurance plans to cover Wegovy. Your healthcare provider will need to submit a form to your insurance company to seek approval. It is recommended to confirm with your insurance provider whether prior authorization is required and to understand the specific process and criteria needed.
Additionally, the cost of Wegovy can be a significant factor in insurance coverage. Some insurance plans may offer coverage for Wegovy, which can lower the cost of the prescription. However, if your insurance plan does not cover Wegovy or if your out-of-pocket expenses are high, there may be alternative options. For instance, NovoCare, sponsored by Novo Nordisk (the manufacturer of Wegovy), offers a savings program that can reduce the cost of the medication.
It is worth noting that Medicare does not typically cover weight-loss medications, and the coverage for Wegovy specifically may depend on the state and the reason for its use. On the other hand, some insurance plans may cover Wegovy for cardiovascular risk reduction due to its FDA approval for this indication.
Lastly, it is important to be aware that Wegovy may not be suitable for everyone, and there are potential side effects, including gallbladder problems, inflammation of the pancreas (pancreatitis), and possible thyroid tumours, including cancer. Therefore, it is crucial to consult with your healthcare provider and carefully review your insurance plan's requirements and exclusions to determine if Wegovy is covered and if you meet the necessary criteria.
Accessing Medical Records: Past Insurance Company's Files
You may want to see also
Explore related products
Side effects
Wegovy® may cause several side effects, some of which can be serious. It is important to monitor how your body responds and to inform your healthcare provider of any changes.
One of the most serious potential side effects of Wegovy® is inflammation of the pancreas (pancreatitis). This can cause severe abdominal pain, with or without vomiting, that may spread to the back. If you experience these symptoms, you should stop taking Wegovy® and contact your healthcare provider immediately.
Another serious side effect is gallbladder problems, including gallstones. Some gallstones may require surgery. Symptoms of gallbladder issues include pain in the upper stomach, fever, jaundice (yellowing of the skin or eyes), and clay-coloured stools. If you experience any of these symptoms, you should contact your healthcare provider.
Wegovy® may also increase the risk of low blood sugar (hypoglycaemia), especially in those who take medications for diabetes, such as insulin or sulfonylureas. This can be a serious condition with symptoms like dizziness, blurred vision, anxiety, irritability, sweating, slurred speech, hunger, confusion, drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery. It is important to monitor your blood sugar levels before and during the use of Wegovy® and to discuss any concerns with your healthcare provider.
In studies on rodents, Wegovy® has been linked to the development of thyroid tumours, some of which were cancerous. It is unknown if Wegovy® will cause thyroid tumours or a specific type of thyroid cancer called medullary thyroid carcinoma (MTC) in humans. However, if you experience any symptoms such as a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath, you should inform your healthcare provider as these could be indicative of thyroid cancer.
Other potential side effects of Wegovy® include nausea, vomiting, diarrhoea, and belching. These may be less concerning, but it is still important to monitor them and discuss them with your healthcare provider if they persist or become bothersome. Additionally, Wegovy® can affect your alertness or coordination, leading to dizziness, so caution should be exercised when driving or performing tasks that require alertness or coordination until you know how Wegovy® affects you.
Claiming Double: Medical Insurance from Two Companies
You may want to see also
Frequently asked questions
Medicare does not cover weight-loss medications and does not allow the use of manufacturer’s coupons with a Part D plan. However, as Wegovy has an FDA approval for cardiovascular risk reduction, some Medicare prescription plans may cover it for this use.
NovoCare offers a savings program that can reduce the cost to $650 per month.
You can ask your health care provider to write a letter to your human resources department.
Insurance plans that cover Wegovy typically require that patients meet the following criteria: adults must have an initial body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related medical condition.
